Literature DB >> 30726790

Patients with Acute Ischemic Cerebrovascular Disease with Coronary Artery Stenosis Have More Diffused Cervicocephalic Atherosclerosis.

Qi Kong1, Xin Ma1, Chen Wang2, Wuwei Feng3, Bruce Ovbiagele4, Yuren Zhang5, Xiangying Du2.   

Abstract

AIM: Coronary artery stenosis (CAS) ≥ 50% frequently coexists in patients with acute ischemic cerebrovascular disease (AICVD), which portends unfavorable outcomes. We sought to examine whether patients with AICVD with CAS had more severe and more diffused cervicocephalic atherosclerosis (CA).
METHODS: Patients with AICVD were consecutively enrolled and underwent simultaneous computed tomography angiography (CTA) of the coronary and cervicocephalic arteries. A total of 140 patients were divided into "AICVD+CAS" and "AICVD only" groups according to whether CTA showed stenosis of ≥ 50% in at least one coronary arterial segment. The relationship of the presence of CAS with the severity and extent of CA were examined.
RESULTS: The CA severity characteristics, including the presence of stenosis ≥ 50% and the grade of the most severe stenotic segment, were not significantly different between the two groups. Regarding the extent of CA, the presence of stenosis ≥ 50% in both sides (adjusted odds ratio [OR]: 4.29, 95% confidence interval [CI]: 1.67-10.98), both extracranial and intracranial (adjusted OR: 5.26, 95% CI: 2.24-12.35), both anterior and posterior circulation (adjusted OR: 5.29, 95% CI: 2.22-12.64), and the number of stenotic segments ≥ 50% in cervicocephalic arteries (adjusted OR: 1.58, 95% CI: 1.28-1.96) were associated with CAS in patients with AICVD, independently of clinical demographics and CA severity characteristics.
CONCLUSION: CA was similarly severe in patients with AICVD with and without CAS, but those with CAS had significantly more diffused CA. The extent of CA and CAS were mutual indicators in patients with AICVD, irrespective of CA severity.

Entities:  

Keywords:  Acute ischemic cerebrovascular disease; Cervicocephalic atherosclerosis; Coronary artery stenosis; Extent; Severity

Mesh:

Year:  2019        PMID: 30726790      PMCID: PMC6753244          DOI: 10.5551/jat.47464

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  27 in total

1.  A standardized method for measuring intracranial arterial stenosis.

Authors:  O B Samuels; G J Joseph; M J Lynn; H A Smith; M I Chimowitz
Journal:  AJNR Am J Neuroradiol       Date:  2000-04       Impact factor: 3.825

2.  Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study.

Authors:  M Mazighi; R Tanasescu; X Ducrocq; E Vicaut; S Bracard; E Houdart; F Woimant
Journal:  Neurology       Date:  2006-04-25       Impact factor: 9.910

3.  Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association.

Authors:  Robert J Adams; Marc I Chimowitz; Joseph S Alpert; Issam A Awad; Manuel D Cerqueria; Pierre Fayad; Kathryn A Taubert
Journal:  Stroke       Date:  2003-09       Impact factor: 7.914

Review 4.  Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond.

Authors:  Donald M Lloyd-Jones; Yuling Hong; Darwin Labarthe; Dariush Mozaffarian; Lawrence J Appel; Linda Van Horn; Kurt Greenlund; Stephen Daniels; Graham Nichol; Gordon F Tomaselli; Donna K Arnett; Gregg C Fonarow; P Michael Ho; Michael S Lauer; Frederick A Masoudi; Rose Marie Robertson; Véronique Roger; Lee H Schwamm; Paul Sorlie; Clyde W Yancy; Wayne D Rosamond
Journal:  Circulation       Date:  2010-01-20       Impact factor: 29.690

5.  Associations of extracranial carotid atherosclerosis progression with coronary status and risk factors in patients with and without coronary artery disease.

Authors:  John R Crouse; Rong Tang; Mark A Espeland; James G Terry; Timothy Morgan; Michele Mercuri
Journal:  Circulation       Date:  2002-10-15       Impact factor: 29.690

6.  Intracranial vascular stenosis and occlusive disease: evaluation with CT angiography, MR angiography, and digital subtraction angiography.

Authors:  Suzie Bash; J Pablo Villablanca; Reza Jahan; Gary Duckwiler; Monica Tillis; Chelsea Kidwell; Jeffrey Saver; James Sayre
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

7.  Risk of coronary and other nonstroke vascular death in relation to the presence and extent of atherosclerotic disease at the carotid bifurcation.

Authors:  Emmanuel Touzé; Charles P Warlow; Peter M Rothwell
Journal:  Stroke       Date:  2006-11-02       Impact factor: 7.914

8.  Silent myocardial ischemia in patients with symptomatic intracranial atherosclerosis: associated factors.

Authors:  Juan F Arenillas; Jaume Candell-Riera; Guillermo Romero-Farina; Carlos A Molina; Pilar Chacón; Santiago Aguadé-Bruix; Joan Montaner; Gustavo de León; Joan Castell-Conesa; José Alvarez-Sabín
Journal:  Stroke       Date:  2005-05-05       Impact factor: 7.914

Review 9.  Imaging of vertebral artery stenosis: a systematic review.

Authors:  S Khan; G C Cloud; S Kerry; H S Markus
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02-07       Impact factor: 10.154

10.  Correlation of coronary artery atherosclerosis with atherosclerosis of the intracranial cerebral artery and the extracranial carotid artery.

Authors:  Woo-Keun Seo; Hwan S Yong; Seong-Beom Koh; Sang-il Suh; Ji H Kim; Sung-Wook Yu; Ji-Yeon Lee
Journal:  Eur Neurol       Date:  2008-04-11       Impact factor: 1.710

View more
  3 in total

1.  A Whole-Scope Evaluation of Cervicocephalic Atherosclerotic Burden is Essential to Predict 90-Day Functional Outcome in Large-Artery Atherosclerotic Stroke.

Authors:  Yi Yang; Qi Kong; Xin Ma; Chen Wang; Sufang Xue; Xiangying Du
Journal:  J Atheroscler Thromb       Date:  2021-11-20       Impact factor: 4.394

Review 2.  Therapeutic Effects and Safe Uses of Plant-Derived Polyphenolic Compounds in Cardiovascular Diseases: A Review.

Authors:  Badriyah Shadid Alotaibi; Munazza Ijaz; Manal Buabeid; Zelal Jaber Kharaba; Hafiza Sidra Yaseen; Ghulam Murtaza
Journal:  Drug Des Devel Ther       Date:  2021-11-20       Impact factor: 4.162

3.  Plasma RANTES level is correlated with cardio-cerebral atherosclerosis burden in patients with ischemic cerebrovascular disease.

Authors:  Qi Kong; Xin Ma; Jun-Xuan Lyu; Chen Wang; Xiang-Ying Du; Yun-Qian Guan
Journal:  Chronic Dis Transl Med       Date:  2020-03-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.